Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links
- PMID: 22554795
- PMCID: PMC6220425
- DOI: 10.1016/j.semcancer.2012.04.001
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links
Abstract
The epithelial-mesenchymal transition (EMT) confers mesenchymal properties on epithelial cells and has been closely associated with the acquisition of aggressive traits by carcinoma cells. EMT programs are orchestrated by a set of pleiotropically acting transcription factors (TFs). The actions of these EMT-TFs enable the early steps of metastasis: local invasion and subsequent dissemination of carcinoma cells to distant sites. However, in most malignancies, the subsequent outgrowth of micrometastatic deposits into macroscopic metastases has the greatest impact on clinical progression. Such metastatic "colonization" reflects the ability of disseminated tumor cells to adapt to a foreign tissue microenvironment. The outgrowth of a metastasis is also thought to be associated with self-renewal, the defining cellular trait of cancer stem cells (CSCs), also termed tumor-initiating cells. Importantly, molecular links between EMT-TFs and self-renewal have emerged, suggesting that EMT programs play critical roles both early and late in the metastatic cascade. The genetic and epigenetic mechanisms that regulate the activation of EMT-TFs and the traits they induce are areas under intensive investigation. Such studies may provide new opportunities for therapeutic intervention and help to overcome tumor heterogeneity and therapeutic resistance.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest
The authors declare no conflict of interest.
Figures


Similar articles
-
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis.Cold Spring Harb Perspect Med. 2020 Jul 1;10(7):a036905. doi: 10.1101/cshperspect.a036905. Cold Spring Harb Perspect Med. 2020. PMID: 31570380 Free PMC article. Review.
-
Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.Cells. 2019 Sep 25;8(10):1143. doi: 10.3390/cells8101143. Cells. 2019. PMID: 31557902 Free PMC article. Review.
-
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.Theranostics. 2018 Mar 8;8(8):2202-2216. doi: 10.7150/thno.24003. eCollection 2018. Theranostics. 2018. PMID: 29721073 Free PMC article.
-
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.Oncogene. 2013 Sep 5;32(36):4203-13. doi: 10.1038/onc.2012.441. Epub 2012 Oct 8. Oncogene. 2013. PMID: 23045275
-
Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.BMC Cancer. 2011 Sep 19;11:396. doi: 10.1186/1471-2407-11-396. BMC Cancer. 2011. PMID: 21929801 Free PMC article.
Cited by
-
The Relevance of Circadian Clocks to Stem Cell Differentiation and Cancer Progression.NeuroSci. 2022 Mar 29;3(2):146-165. doi: 10.3390/neurosci3020012. eCollection 2022 Jun. NeuroSci. 2022. PMID: 39483369 Free PMC article. Review.
-
Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma.Tumour Biol. 2015 May;36(5):3417-22. doi: 10.1007/s13277-014-2976-8. Epub 2014 Dec 21. Tumour Biol. 2015. PMID: 25527159
-
Peroxiredoxin 1 promotes invasion and migration by regulating epithelial-to-mesenchymal transition during oral carcinogenesis.Oncotarget. 2016 Jul 26;7(30):47042-47051. doi: 10.18632/oncotarget.9705. Oncotarget. 2016. PMID: 27259998 Free PMC article.
-
Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.Cancer Res. 2013 Jun 15;73(12):3649-60. doi: 10.1158/0008-5472.CAN-12-3832. Cancer Res. 2013. PMID: 23771907 Free PMC article.
-
[Ways to personalized medicine for gastric cancer].Pathologe. 2013 Sep;34(5):403-12. doi: 10.1007/s00292-013-1785-y. Pathologe. 2013. PMID: 23907566 Review. German.
References
-
- Geiger TR, Peeper DS. Metastasis mechanisms. Biochimica et Biophysica Acta 2009;1796(2):293–308. - PubMed
-
- Fidler IJ. Critical determinants of metastasis. Seminars in Cancer Biology 2002;12(2):89–96. - PubMed
-
- Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell 2009;139(5):871–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources